Barclays PLC Gsk PLC Call Options Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 11, 2021
SELL
$34.07 - $39.94 $10,221 - $11,982
-300 Reduced 18.75%
1,300 $48,000
Q3 2020

Nov 12, 2020
SELL
$38.11 - $42.99 $152,440 - $171,960
-4,000 Reduced 71.43%
1,600 $60,000
Q2 2020

Aug 12, 2020
SELL
$37.87 - $43.58 $2.43 Million - $2.8 Million
-64,200 Reduced 91.98%
5,600 $228,000
Q1 2020

May 13, 2020
SELL
$32.47 - $48.83 $1.39 Million - $2.09 Million
-42,900 Reduced 38.07%
69,800 $2.65 Million
Q4 2019

Feb 10, 2020
SELL
$42.0 - $48.25 $651,000 - $747,875
-15,500 Reduced 12.09%
112,700 $5.3 Million
Q3 2019

Nov 14, 2019
SELL
$40.46 - $43.52 $582,624 - $626,688
-14,400 Reduced 10.1%
128,200 $5.47 Million
Q2 2019

Aug 14, 2019
BUY
$39.4 - $42.7 $3.32 Million - $3.6 Million
84,300 Added 144.6%
142,600 $5.71 Million
Q1 2019

May 15, 2019
SELL
$38.57 - $42.69 $3.05 Million - $3.38 Million
-79,200 Reduced 57.6%
58,300 $2.44 Million
Q4 2018

Feb 14, 2019
BUY
$37.8 - $42.69 $64,259 - $72,573
1,700 Added 1.25%
137,500 $5.25 Million
Q3 2018

Nov 14, 2018
SELL
$39.75 - $42.69 $1.53 Million - $1.64 Million
-38,400 Reduced 22.04%
135,800 $5.46 Million
Q2 2018

Aug 14, 2018
SELL
$39.61 - $42.76 $3.43 Million - $3.7 Million
-86,600 Reduced 33.21%
174,200 $7.02 Million
Q1 2018

May 15, 2018
BUY
$36.18 - $40.15 $5.17 Million - $5.74 Million
142,900 Added 121.2%
260,800 $10.2 Million
Q4 2017

Feb 14, 2018
SELL
$35.34 - $41.9 $2.23 Million - $2.65 Million
-63,200 Reduced 34.9%
117,900 $4.18 Million
Q3 2017

Nov 14, 2017
BUY
$39.44 - $41.55 $7.14 Million - $7.52 Million
181,100
181,100 $7.35 Million

Others Institutions Holding GSK

# of Institutions
20
Shares Held
176K
Call Options Held
0
Put Options Held
0
View Full List

About GSK PLC

GSK Quotes by TradingView
  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email